论文部分内容阅读
1964年Tatarinow 发现原发性肝癌病人血清中含有甲种胎儿蛋白后(以下称AFP),引起了人们的重视,认为该测定对诊断原发性肝癌具有特异性,但也曾报道过病毒性肝炎病人血清中亦可检测到此种蛋白。为了摸清AFP在病毒性肝炎病人中的演变规律,及便于同原发性肝癌鉴别,我们应用放射火箭电泳自显影术,自1979年1月至10月,对我院住院及门诊病毒性肝炎及其它肝病患者155例做了血清AFP 含量测定,并以267名健康人作对照观察,现初步总结如下。材料方法及检测对象一、病例选择以1978年全国病毒性肝炎防治方案的诊断分型标准为依据,检查各型肝病155例,其中急性肝炎49例,慢性活动性肝炎(以下称慢活肝)45例,迁延性肝炎20例,
In 1964, Tatarinow found that the serum of patients with primary liver cancer contains A-fetoprotein (hereinafter referred to as AFP), has drawn people’s attention, that the assay is specific for the diagnosis of primary liver cancer, but also reported viral hepatitis This protein can also be detected in the patient’s serum. In order to find out the evolution of AFP in patients with viral hepatitis, and to facilitate the identification of primary liver cancer, we use radiological rocket electrophoresis autoradiography, from January 1979 to October, our hospital and outpatient viral hepatitis And other liver disease in 155 cases of patients with serum AFP determination, and 267 healthy controls for the control, are initially summarized as follows. Material Methods and Test Object I. Case Selection Based on the diagnostic criteria of 1978 National Viral Hepatitis Control Program, 155 cases of various types of liver diseases were examined, including 49 cases of acute hepatitis, chronic active hepatitis (hereinafter referred to as slow-living liver) 45 cases, 20 cases of persistent hepatitis,